tumor microenvironment

You have access
Determination of Cuproptosis-related Subtypes, Development of a Prognostic Model, and Characterization of Tumor Microenvironment Infiltration in Acute Myeloid Leukemia
YUCHEN TAO, JIANYE REN, TINGTING XUE, YANLU WANG, HAO XU, HONGYU ZHANG and JIAHUI LU

Anticancer Research September 2023, 43 (9) 3943-3960; DOI: https://doi.org/10.21873/anticanres.16582
You have access
ATG9B Is a Poor Prognostic Marker Associated With Immune Evasion in Colon Adenocarcinoma
IN SOO KIM, SANG YEON CHO, MISO YANG, SONGYEON HAN, KYUNG-HA LEE, JI YEON KIM, JIN MAN KIM, SORA KANG, EUN-KYEONG JO and HYEWON RYU

Anticancer Research May 2023, 43 (5) 1943-1957; DOI: https://doi.org/10.21873/anticanres.16354
You have access
TU-100 Antagonizes the M2 Polarization Phenotype of Macrophages in the Tumor Microenvironment by Suppressing the TLR4/NF-B/STAT3 Axis
SHUHAI CHEN, YUJI MORINE, YU SAITO, SHINICHIRO YAMADA, HIROKI TERAOKU, TETSUYA IKEMOTO and MITSUO SHIMADA

Anticancer Research May 2023, 43 (5) 1985-1992; DOI: https://doi.org/10.21873/anticanres.16359
You have access
Epithelial–Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer
CHUNG RYUL OH, HYUNG-DON KIM, YEON-MI RYU, SEONMIN LEE, DANBEE KIM, DA SOL LEE, JAE HO JEONG, HEUNG-MOON CHANG, BAEK-YEOL RYOO, KYU-PYO KIM, MIYEON KIM, SANG-YEOB KIM and CHANGHOON YOO

Anticancer Research February 2023, 43 (2) 645-652; DOI: https://doi.org/10.21873/anticanres.16201
Open Access
Inhibition of STAT3 Promotes Effector T Cell Infiltration But also Immunosuppression in the HCC Tumor Microenvironment
TAKETO SASAKI, KOHEI SHIGETA, SHUJI KITAHARA, YASUHIRO SUZUKI, SHIMPEI MATSUI, RYO SEISHIMA, KOJI OKABAYASHI, DAN G. DUDA and YUKO KITAGAWA

Anticancer Research November 2022, 42 (11) 5205-5215; DOI: https://doi.org/10.21873/anticanres.16027
You have access
Effects of Cyclooxygenase-2 in Canine Melanoma-derived Extracellular Vesicles on Tumor Microenvironment In Vitro
NA-HYEONG KIM, JU-HYUN AN, JEONG-HWA LEE, SU-MIN PARK, KYEONG-BO KIM, TAE-HYUN KIM, YE-IN OH, KYEONG-WON SEO and HWA-YOUNG YOUN

Anticancer Research November 2022, 42 (11) 5397-5405; DOI: https://doi.org/10.21873/anticanres.16044
You have access
Preparation of Micelles Encapsulating Doxorubicin and Their Anticancer Effect in Combination With Tranilast in 3D Spheroids and In Vivo
TERUKI NII, KANJI YOSHIKAWA, ISSEI TAKEUCHI and KIMIKO MAKINO

Anticancer Research June 2022, 42 (6) 2847-2857; DOI: https://doi.org/10.21873/anticanres.15766
You have access
Epstein-Barr Virus-induced Gene 3 as a Novel Biomarker in Metastatic Melanoma With Infiltrating CD8⁺ T Cells: A Study Based on The Cancer Genome Atlas (TCGA)
SATORU YONEKURA

Anticancer Research January 2022, 42 (1) 511-517; DOI: https://doi.org/10.21873/anticanres.15509
You have access
New Insights as to Why Progesterone Receptor Modulators, such as Mifepristone, Seem to Be More Effective in Treating Cancers that Are Devoid of the Classical Nuclear Progesterone Receptor
JEROME H. CHECK and DIANE CHECK

Anticancer Research December 2021, 41 (12) 5873-5880; DOI: https://doi.org/10.21873/anticanres.15407
You have access
Involvement of Galectin-1 Tumor Microenvironment in Radiosensitivity
YI-FAN CHEN, CHUNG-CHI WANG, CHIEH-YING HSU and ENG-YEN HUANG

Anticancer Research May 2021, 41 (5) 2321-2331; DOI: https://doi.org/10.21873/anticanres.15007

Main menu

User menu

Search

tumor microenvironment

Pages